Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Diabetic Foot | Case report

An atypical and bilateral presentation of Charcot foot disease

Authors: C. V. Loupa, E. Meimeti, A. Kokas, E. D. Voyatzoglou, A. Donou

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Charcot neuropathic osteoarthropathy (CNO) is one of the most devastating complications of neuropathy in patients with diabetes. Establishing diagnosis of CNO is difficult, due to the lack of clear clinical and radiological diagnostic criteria. Diagnosis is even more difficult when there is atypical and bilateral clinical presentation. Since CNO may lead to foot deformity, lower-extremity amputation and significant decrements in quality of life, it must be detected and treated without delay. Treatment focuses mainly on interruption of the inflammatory process and relief from pain using feet offloading devices. In more severe cases, surgical intervention may be needed. Additionally, the use of custom-made insoles and custom-made orthopaedic shoes is mandatory.

Case presentation

We report a case of a young diabetic patient who presented to our clinic with bilateral and atypical presentation of Charcot foot disease. Patient was treated successfully upon diagnosis with bilateral aircast offloading. Unfortunately, due to depression and non-compliance, the disease progressed to severe and permanent lesions later on.

Conclusion

Despite the rareness of this disease, clinicians must include CNO into differential diagnosis of diabetic foot oedema, inflammation and deformity.
Literature
2.
go back to reference Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabetic Med. 2005;22:1707–12.CrossRefPubMed Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabetic Med. 2005;22:1707–12.CrossRefPubMed
3.
go back to reference Petrova NL, Moniz C, Elias DA, Buxton-Thomas M, Bates M, Edmonds ME. Is there a systemic inflammatory response in the acute charcot foot? Diabetes Care. 2007;30:997–8.CrossRefPubMed Petrova NL, Moniz C, Elias DA, Buxton-Thomas M, Bates M, Edmonds ME. Is there a systemic inflammatory response in the acute charcot foot? Diabetes Care. 2007;30:997–8.CrossRefPubMed
5.
go back to reference Molines L, Darmon P, Raccah D. Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;364:251–5.CrossRef Molines L, Darmon P, Raccah D. Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;364:251–5.CrossRef
7.
go back to reference Ulbrecht JS, Wukich DK. The Charcot foot: medical and surgical therapy. Curr Diab Rep. 2008;8:444–51.CrossRefPubMed Ulbrecht JS, Wukich DK. The Charcot foot: medical and surgical therapy. Curr Diab Rep. 2008;8:444–51.CrossRefPubMed
8.
9.
go back to reference Charcot J-M, Fere C. Affections osseuses et articulaires du pied chez les tabétiques (Pied tabétique). Archives de Neurologie. 1883;6:305–19 in French. Charcot J-M, Fere C. Affections osseuses et articulaires du pied chez les tabétiques (Pied tabétique). Archives de Neurologie. 1883;6:305–19 in French.
10.
go back to reference Weckbach S, Flierl MA, Blei M, Burlew CC, Moore EE, Stahel PF. Survival following a vertical free fall from 300 ft: The crucial role of body position to impact surface. Scand J Trauma Resusc Emerg Med. 2011;19:63.CrossRefPubMedPubMedCentral Weckbach S, Flierl MA, Blei M, Burlew CC, Moore EE, Stahel PF. Survival following a vertical free fall from 300 ft: The crucial role of body position to impact surface. Scand J Trauma Resusc Emerg Med. 2011;19:63.CrossRefPubMedPubMedCentral
12.
go back to reference Fauzi AA, Yang CT. Bilateral diabetic Charcot foot. Aust Fam Physician. 2013;42:55–6.PubMed Fauzi AA, Yang CT. Bilateral diabetic Charcot foot. Aust Fam Physician. 2013;42:55–6.PubMed
13.
go back to reference Gutekunst DJ, Sinacore DR. Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports. J Orthop Sports Phys Ther. 2013;43:744–51.CrossRefPubMedPubMedCentral Gutekunst DJ, Sinacore DR. Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports. J Orthop Sports Phys Ther. 2013;43:744–51.CrossRefPubMedPubMedCentral
14.
go back to reference Renner N, Wirth SH, Osterhoff G, et al. Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients. BMC Musculoskelet Disord. 2016;17:504.CrossRefPubMedPubMedCentral Renner N, Wirth SH, Osterhoff G, et al. Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients. BMC Musculoskelet Disord. 2016;17:504.CrossRefPubMedPubMedCentral
Metadata
Title
An atypical and bilateral presentation of Charcot foot disease
Authors
C. V. Loupa
E. Meimeti
A. Kokas
E. D. Voyatzoglou
A. Donou
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0422-z

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.